A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Rifampin Capsules

NCT03758469 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Anesthesia
Sedation

Interventions

DRUG: HSK3486
DRUG: rifampin , HSK3486

Sponsor

Sichuan Haisco Pharmaceutical Group Co., Ltd